Skip to main content
. 2011 Oct;55(10):4755–4764. doi: 10.1128/AAC.00671-11

Table 4.

In vivo efficacy of treatment with CKOMe

Treatment/compounda Result of treatment at end of study (%)
Clinical cure Failure Clinical improvement
CKOMe without light 67 0 33
CKOMe + 2 h of light 67 33 0
CKOMe + 4 h of light 83 17 0
Meglumine antimoniate, curative dose 67 33 0
Meglumine antimoniate, subcurative dose 67 33 0
a

n = 6 animals per group.